Because Heart Matters!

Millions suffer from severe heart disease, and for over 400.000 patients each year, TAVI isn’t an option due to age, co-morbidities or long-term considerations. For them, traditional open-heart surgery remains the only solution, requiring:

• Opening the chest and stopping the heart
• Using a heart-lung machine
• Precise repair or replacement of the valve

Even in state-of-the-art operating rooms, surgeons face challenges when assessing valve function under non-natural conditions. Traditional tools like rulers and saline tests, though reliable, lack the precision required for today’s complex surgeries, leading to:

• Longer surgery times
• Risk of reoperations

Klavant transforms cardiac surgery with AI-driven tools that enhance precision and decision-making. Our goal is to enable surgeons to:

• Accurately measure valve competence with natural pressure conditions
• Visualize structures in real-time with exceptional clarity
• Make data-driven decisions that improve outcomes and reduce risks

By integrating AI and advanced imaging, Klavant empowers surgeons to perform with even greater precision, ensuring better outcomes for patients.

Klavant is an innovative MedTech company in the pre-clinical stage, focused on developing AI-powered solutions for cardiac surgery. Our AI-driven tools aim to provide heart surgeons with insights, enhancing precision during valve repair and replacement procedures. These solutions are designed to improve decision-making, reduce risks and optimize surgical outcomes.

Klavant is revolutionizing cardiac surgery with AI-powered tools that enhance precision and decision-making. Our technology equips surgeons with advanced capabilities for more accurate measurements, better visualization and data-driven support, offering significant benefits such as:

• Faster surgeries: reducing time spent on critical procedures, improving patient safety and outcomes
• Preventing re-operation: improved surgical outcome plus aortic valve competence will decrease re-operation
• Cost savings for healthcare systems: minimizing complications and improving efficiency, leading to optimized resource use and less post-operative treatment costs
• Decrease lifelong medication: necessary medication for patient due to aortic valve insufficiency and side effects can be reduced

Through these innovations, Klavant aims to improve patient outcomes, reduce reoperation rates and redefine the standard of care in heart valve surgery.